Peptides DB
Research-centric peptide and protocol reference hub
Study 14 of 19Snap-8 literatureInfectious Disease Modelling · Review2026

Quantitative risk assessment of avian influenza: A scoping review.

Quantitative models are crucial for avian influenza risk assessment, but inconsistencies in methodologies limit their comparability and reproducibility.

Read at Infectious Disease ModellingAdd to compare

Where it sits

this study against the rest of the snap-8 corpus
2
Preclinical
16
Observational
0
Open-label
0
Randomised
1
Reviews · this one

Summary and findings

This scoping review assessed quantitative models used in avian influenza risk assessment, identifying five categories of models applied to 34 studies from 2020 to 2025. The review highlighted methodological inconsistencies and the need for harmonized workflows to improve reproducibility. It did not focus on Snap-8 or peptide-related outcomes.

How much of this paper we could read: full text read (0.90). We had a clear abstract, so the summary below closely tracks the paper. What this means →
34 eligible studies identified from January 2020 to March 2025.n=342026

Abstract

The authors’ words, as Infectious Disease Modelling supplied them

Avian influenza virus (AIV) continues to pose serious risks to animal and public health. Understanding its spread requires integrating ecological, agricultural, and human information. Quantitative models provide a practical way to represent these interactions, evaluate multiple risk factors, and generate spatial insights that support early detection and control. In recent years, advances in data availability and computational methods have increased the use of these models for AIV risk assessment. This review mapped how quantitative modelling has been applied to AIV risk assessment in recent years. Following PRISMA-ScR guidelines, we searched PubMed, Web of Science, and ProQuest for studies published between January 2020 and March 2025, identifying 34 eligible studies. Five model categories were identified: Logistic Regression-based Models, Generalized Linear Models (GLMs), Machine Learning (ML), Multi-Criteria Decision Analysis (MCDA), and Exploratory Statistical Models. Logistic regression and GLMs quantified associations between outbreaks and risk factors, while ML models focused on predictive mapping. MCDA combined expert weighting with spatial data to generate composite risk maps, and exploratory analyses examined spatial and temporal outbreak patterns. Despite methodological progress, inconsistencies remain in data preparation and validation, limiting comparability across studies. Clearer, harmonized workflows are needed to improve reproducibility and support translation into surveillance tools globally.

Background

Avian influenza virus poses significant risks to both animal and public health, necessitating effective risk assessment strategies. Quantitative models have become increasingly important for understanding the spread of AIV by integrating various ecological, agricultural, and human data. This study is significant as it reviews the application of these models in recent years, highlighting advances and ongoing challenges in the field.

Methods

This scoping review followed PRISMA-ScR guidelines, searching PubMed, Web of Science, and ProQuest for studies published between January 2020 and March 2025. A total of 34 studies were identified and categorized into five model types: Logistic Regression-based Models, Generalized Linear Models, Machine Learning, Multi-Criteria Decision Analysis, and Exploratory Statistical Models.

Results

The review identified five categories of quantitative models used in AIV risk assessment. Logistic regression and GLMs were used to quantify associations between outbreaks and risk factors. Machine Learning models focused on predictive mapping, while MCDA combined expert weighting with spatial data to create composite risk maps. Exploratory statistical models examined spatial and temporal outbreak patterns. Despite these advances, the review noted inconsistencies in data preparation and validation.

Interpretation

The review highlights the diverse approaches used in AIV risk assessment, with each model type offering unique strengths. However, the inconsistencies in data handling and validation across studies present challenges for reproducibility and comparability. This suggests that while methodological advancements have been made, further standardization is needed to enhance the utility of these models in practical surveillance applications.

Key findings

  • 34 eligible studies identified from January 2020 to March 2025.
  • Five model categories: Logistic Regression, GLMs, ML, MCDA, Exploratory Statistical Models.
  • Logistic regression and GLMs quantified associations between outbreaks and risk factors.
  • Machine Learning models focused on predictive mapping.
  • MCDA combined expert weighting with spatial data for composite risk maps.

Limitations

  • Inconsistencies in data preparation and validation.
  • Limited comparability across studies.
  • Focus on methodological review rather than new empirical data.

Elsewhere in the Snap-8 corpus

BMapping the resistance landscape: A large-scale study of polymyxin-resistant pathogens circulating in low-and middle-income countriesbiorxiv-preprint · 2026 · Not reported in abstract.HumanCCobalt-Based Drug Delivery to the Brain using Rapid Short-Pulses of Focused Ultrasound and Microbubbles reduces Aβ aggregation in 5XFAD micebiorxiv-preprint · 2026 · 60.5% reduction in Aβ plaque area.AnimalBCorrelates of protection against SARS-CoV-2 shedding in a controlled human infection study in immune-experienced participantsbiorxiv-preprint · 2026 · Not reported in abstract.HumanCRotavirus-NSP5 interacts with and hijacks host ATP citrate lyase to viroplasms, enhancing lipid biosynthesis for facilitating rotavirus infection.Virulence · 2026 · Not reported in abstract.AnimalCChebulinic acid suppresses NF-κB/TSLP signaling axis via ACLY-mediated lipid metabolism reprogramming to ameliorate atopic dermatitis.Journal of ethnopharmacology · 2026 · Not reported in abstract.AnimalBTargeted Long-Read sequencing provides functional validation of variants predicted to alter splicingbiorxiv-preprint · 2026 · Not reported in abstract.Human